Avoid voriconazole in transplant patients at risk for skin cancer

SAN FRANCISCO – Voriconazole increased the risk of squamous cell carcinoma by 73% in a review of 455 lung transplant patients at the University of California, San Francisco. The increase was for any exposure to the drug after transplant (adjusted hazard ratio, 1.73; P = .03). The...
Source: Skin and Allergy News - Category: Dermatology Tags: FPN Conferences IMN Conferences SAN Conference News SN Conferences SN News FPN News FPN Dermatology FPN Oncology HOSP News Source Type: news